Grantham, Mayo, Van Otterloo & Co (GMO)’s Arch Capital ACGL Stock Holding History
Bought
Maintained
Sold
Other funds holding ACGL
Grantham, Mayo, Van Otterloo & Co (GMO)'s ACGL Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Arch Capital (ACGL) stake by 34% in Q2 2026, buying an estimated $3.76M and bringing the position to 156,236 shares worth $15.2M. The position accounts for 0.03% of the portfolio, ranked #217.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACGL in Q2 2013 and has held it in 26 quarters since. The position peaked at $36.4M in Q1 2025. 906 funds tracked by Wall St. Rank hold ACGL as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 156,236 shares of Arch Capital worth $15.2M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 39,904 Arch Capital shares in Q2 2026, an estimated $3.76M.
- Arch Capital made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #217 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Arch Capital in Q2 2013 and has held it in 26 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Arch Capital position peaked at $36.4M in Q1 2025.
- 906 funds tracked by Wall St. Rank held Arch Capital as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.